Gabapentin for Alcohol Relapse Prevention

This treatment study is a 16-weeks outpatient clinical trial where subjects will get
medication, which might help them to reduce or stop their drinking or a placebo ( placebo is
a capsule that looks the same as the investigational drug, but has no real medication. It is
a "sugar pill"). This study will recruit and randomize subjects who have expressed an
interest in receiving treatment for alcohol dependence. Upon enrollment into this study there
will be 11 outpatient visits. Each visit will last about 1-1.5 hours.

Inclusion Criteria:

1. Meets criteria for alcohol use disorder based on DSM-5 criteria

2. Meets criteria for history of alcohol withdrawal based on DSM-5 criteria

3. Able to maintain abstinence for a minimum of 3 days prior to randomization as verified
by self report, urine ETG, and breathalyzer.

Exclusion Criteria:

1. Significant psychiatric or medical illness

2. No other substance abuse

3. Taking other medications known to treat alcohol use disorder

4. Unstable living arrangements

5. Significant legal problems pending